Compounds > thymidine
Page last updated: 2024-08-17

thymidine and imatinib mesylate

thymidine has been researched along with imatinib mesylate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkins, RC; Chadban, SJ; Hurst, LA; Nikolic-Paterson, DJ; Robertson, TE1
Alberti, D; Bungaro, S; Corneo, G; D'Incalci, M; Frapolli, R; Gambacorti-Passerini, C; Pioltelli, P; Pogliani, E; Rossi, F; Russo, D; Tornaghi, L; Verga, M; Zucchetti, M1
Brabant, G; Jakubcakova, V; Kant, S; Kremenevskaja, N; Rao, AS; Resch, J; von Wasielewski, R1
Aguillon, RA; Carson, DA; Castro, JE; Dicker, F; Fukuda, T; Kipps, TJ; Kitada, S; Motta, M; Prada, CE; Reed, JC; Sun, G; Wang, JY; Wu, C1
Aichberger, KJ; Esterbauer, H; Gleixner, KV; Greish, K; Gruze, A; Kondo, R; Krauth, MT; Maeda, H; Mayerhofer, M; Pickl, WF; Samorapoompichit, P; Sillaber, C; Valent, P; Vales, A1
Caruso, M; de Campos-Lima, PO; Ghani, K; Naud, JS1

Trials

1 trial(s) available for thymidine and imatinib mesylate

ArticleYear
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:2

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzamides; Blast Crisis; Cell Division; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Nude; Orosomucoid; Piperazines; Protein Binding; Pyrimidines; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured

2003

Other Studies

5 other study(ies) available for thymidine and imatinib mesylate

ArticleYear
IL-10 induces mesangial cell proliferation via a PDGF-dependent mechanism.
    Clinical and experimental immunology, 2002, Volume: 130, Issue:2

    Topics: Animals; Autocrine Communication; Benzamides; Cell Division; Cell Line; Enzyme Inhibitors; Glomerular Mesangium; Imatinib Mesylate; Interleukin-10; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Rats; Rats, Sprague-Dawley; Thymidine

2002
Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; beta Catenin; Blotting, Western; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Proliferation; Collagen; Drug Combinations; Fluorescent Antibody Technique; Genes, Reporter; Humans; Imatinib Mesylate; Immunoprecipitation; Laminin; Luciferases; Microscopy, Confocal; Oligonucleotide Array Sequence Analysis; Piperazines; Proteoglycans; Pyrimidines; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Thyroid Neoplasms; Transfection; Tumor Cells, Cultured

2006
Thymidine-phosphorothioate oligonucleotides induce activation and apoptosis of CLL cells independently of CpG motifs or BCL-2 gene interference.
    Leukemia, 2006, Volume: 20, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; B-Lymphocytes; Benzamides; BH3 Interacting Domain Death Agonist Protein; Caspases; Cell Survival; CpG Islands; Drug Screening Assays, Antitumor; Enzyme Activation; Genes, bcl-2; Humans; Imatinib Mesylate; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Oligodeoxyribonucleotides; Organothiophosphorus Compounds; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-abl; Pyrimidines; Structure-Activity Relationship; Thymidine; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation

2006
Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells.
    Blood, 2007, Jul-15, Volume: 110, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Survival; Doxycycline; Gene Expression Regulation, Neoplastic; Heme Oxygenase-1; Humans; Imatinib Mesylate; Mast Cells; Piperazines; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Thymidine

2007
Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.
    Leukemia research, 2012, Volume: 36, Issue:10

    Topics: Benzamides; Cytarabine; Drug Therapy, Combination; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thymidine; Tumor Cells, Cultured

2012